Laryngeal Mask Airway (LMA) Complication in Children

• Sponsor: Seoul National University Bundang Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT02644226
• Collaborator: (none)
• Enrollment: 3,528
• Duration (Months): 2

Study Details

Study Description

Brief Summary

Desflurane is known to be the most pungent of the currently used volatile anesthetics. The investigators tried to find out if desflurane increases the incidence of perioperative upper airway complications in infants and children undergoing general anesthesia using supraglottic airways compared to sevoflurane.

Condition or Disease	Intervention/Treatment	Phase
Laryngeal Mask Airway	Other: Sevoflurane; Other: Desflurane

Detailed Description

The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane or desflurane as maintenance agents.

Study Design

• Study Type: Observational
• Actual Enrollment: 3528 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Retrospective Investigation of Perioperative Upper Airway Complications After Anesthesia Using Supraglottic Airway Devices in Children: Comparison of Desflurane and Sevoflurane
• Study Start Date: Nov 1, 2015
• Actual Primary Completion Date: Jan 1, 2016
• Actual Study Completion Date: Jan 1, 2016

Arms and Interventions

Arm	Intervention/Treatment
Sevoflurane The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane as maintenance agents.	Other: Sevoflurane; The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane as maintenance agents.
Desflurane The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using desflurane as maintenance agents.	Other: Desflurane; The investigators retrospectively reviewed and analyzed the electrical medical records of consecutive children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using desflurane as maintenance agents.

Outcome Measures

Primary Outcome Measures

1. Occurrence of Laryngospasm [intraoperative]

2. Occurrence of Cough [intraoperative]

3. Occurrence of desaturation [intraoperative]

Secondary Outcome Measures

1. Occurrence of Laryngospasm [through study completion, an average of 1 day]

2. Occurrence of desaturation [through study completion, an average of 1 day]

3. Occurrence of Cough [through study completion, an average of 1 day]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 1 Year to 15 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Children aged 1 to 15 years who underwent general anesthesia under supraglottic airways using sevoflurane or desflurane as maintenance agents

Exclusion Criteria:

• Tracheal intubation

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Seoul National University Bundang Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: AH-YOUNG OH, Dr., Seoul National University Bundang Hospital
• ClinicalTrials.gov Identifier: NCT02644226
• Other Study ID Numbers: B-1407/258-117
• First Posted: Dec 31, 2015
• Last Update Posted: May 18, 2016
• Last Verified: May 1, 2016

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Additional relevant MeSH terms: Sevoflurane; Desflurane

Study Results

No Results Posted as of May 18, 2016